Guardant Health CPO reports RSU vesting, tax withholding
Guardant Health reported that Chief People Officer Terilyn J. Monroe had 17,379 Restricted Stock Units settle into 17,379 shares of Common Stock on January 15, 2026.
Rhea-AI Filing Summary
Guardant Health reported that Chief People Officer Terilyn J. Monroe had 17,379 Restricted Stock Units settle into 17,379 shares of Common Stock on January 15, 2026. Of these, 8,808 shares were retained by the company at $111.98 per share to satisfy tax withholding obligations, and she now holds 29,561 shares of Common Stock directly. The underlying RSU award was granted on February 26, 2024 and vests 33% on the one-year anniversary of January 15, 2024, with the remaining 67% vesting annually over the following two-year period.
Positive
- None.
Negative
- None.
Insider Trade Summary
17,379 shares exercised/converted
Exercise
3 txns
Insider
Monroe Terilyn J.
Role
Chief People Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 17,379 | $0.00 | $0.00 |
| Exercise | Common Stock | 17,379 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 8,808 | $111.98 | $986K |
Holdings After Transaction:
Restricted Stock Units — 17,379 contracts (Direct);
Common Stock — 29,561 shares (Direct)
Footnotes (3)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on the one-year anniversary of January 15, 2024 and the remaining 67% of the shares vest annually over the remaining two-year period, thereafter.
- F3. Not applicable for Restricted Stock Units.
Key Figures
RSUs vested and converted: 17,379 shares
Shares retained for taxes: 8,808 shares
Tax withholding price per share: $111.98
+3 more
6 metrics
RSUs vested and converted
17,379 shares
Restricted Stock Units settled into Common Stock on January 15, 2026
Shares retained for taxes
8,808 shares
Shares retained by the company to meet tax withholding obligations
Tax withholding price per share
$111.98
Per-share value applied when 8,808 shares were retained for taxes
Common Stock held directly
29,561 shares
Post-transaction direct holdings of Terilyn J. Monroe
Initial vesting portion
33%
Portion of RSU award vesting on the one-year anniversary of January 15, 2024
Remaining vesting portion
67%
Portion vesting annually over the subsequent two-year period
Key Terms
Restricted Stock Units, tax withholding obligations, vesting
3 terms
Restricted Stock Units financial
"had 17,379 Restricted Stock Units settle into 17,379 shares of Common Stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"retained by the company to meet the tax withholding obligations of the award-holder"
vesting financial
"RSU award granted on February 26, 2024 and vests over a three-year period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What RSU vesting did Guardant Health (GH) report for Terilyn J. Monroe?
Guardant Health reported that Chief People Officer Terilyn J. Monroe had 17,379 Restricted Stock Units settle into 17,379 shares of Common Stock on January 15, 2026. This reflects a scheduled conversion of her equity award rather than a market purchase or open-market sale.
What are Terilyn J. Monroe’s Guardant Health (GH) holdings after this transaction?
After the reported RSU settlement and tax withholding, Terilyn J. Monroe directly holds 29,561 shares of Guardant Health Common Stock. This post-transaction balance reflects her remaining direct ownership position as reported in the canonical holdings section of the filing data.
How does the RSU award for Guardant Health (GH)’s CPO vest over time?
The RSU award, granted on February 26, 2024, vests over three years: 33% vests on the one-year anniversary of January 15, 2024, and the remaining 67% vests in annual installments over the next two-year period, according to the filing’s footnote disclosure.
What types of transactions are reported in this Guardant Health (GH) Form 4?
The Form 4 reports a derivative exercise/conversion of Restricted Stock Units into Common Stock and a tax-withholding disposition where 8,808 shares were retained by the company. These actions relate to equity award vesting rather than discretionary open-market trading activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
